Breshkovska, Gorica
Preferred name
Breshkovska, Gorica
Official Name
Breshkovska, Gorica
Main Affiliation
Email
gorica.breshkovska@medf.ukim.edu.mk
9 results
Now showing 1 - 9 of 9
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, LEUKOTRIENE RECEPTOR ANTAGONISTS IN MANAGING SEVERE UNCONTROLLED ASTHMA(European Medical Group, 2017-08-03); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, IL-33 in patients with severe uncontrolled allergic asthma(European Respiratory Society, 2017-09); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The rationality of the use of NIV in elderly patients with acute COPD exacerbation(European Respiratory Society, 2018-09-15); ; ; ; Jovanoski, Smilko - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma(European Respiratory Journal, 2017-09); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Key Issues in the Management of Multi-Drug Resistant Tuberculosis: A Case Report(ID-Design/Scientific foundation SPIROSKI, 2018-07-20); ; ; Global tuberculosis (TB) epidemic is being driven to an increasing extent by the emergence and spread of drug-resistant strains of Mycobacterium tuberculosis complex (MTBC). We present a case of primary multidrug-resistant tuberculosis (MDR-TB), highlighting Macedonian MDR-TB management issues. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Leukotriene receptor antagonist (LTRA) added to regular preventive therapy: inhaled corticosteroids and longacting beta agonists (ICS/LABA) in patients with severe uncontrolled asthma(Macedonian Pharmaceutical Association, 2020-10-29); ; ; ; Goseva, Zlatica - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ROLE AND CLINICAL SIGNIFICANCE OF IL-33 IN PATIENTS WITH ASTHMA(Macedonian Medical Association / Walter DeGruyter, 2017); ; Goseva, ZlaticaIntroduction. Asthma is a chronic inflammatory disease of the airways in which many cells play a role with secreting a variety of mediators responsible for the clinical manifestation of asthma. It is assumed that IL-33 is one of the earliest-released mediators and can orchestrate the immune cascade of the disease. The aimof this study was to examine the role and clinical significance of IL-33 as a new and insufficiently explored mediator of inflammation in patients with uncontrolled moderate asthma. Methods. The study included 87 patients with asthma. Serum IL-33 was measured in all patients by ELISA method. The obtained data were statistically analyzedusing the Kolmogorov-Smirnov and ShapiroWilk's test. Qualitative data were presented in absolute and relative numbers, and quantitative data were presented with measures of descriptive statistics. Statistically significant values were considered for p <0.05. Results. Majority of included patients were female (75.86%). The average age of patients was 42.3±15.9 years. The results of IL-33 in all patients were significantly increased compared to the reference value of IL-33 which is 0 pg/ml. The average values of IL-33 ranged from 6.47±29.3 and they were insignificantly higher in the group with female patients compared to males (p=0.27), and insignificantly correlated with age (p=0.26). Conclusion. Even though a limited number of studies have explored the IL-33, results have shown higher serum level of IL-33 in asthma patients compared to healthy people, emphasizing the fact that IL-33 is an attractive candidate for targeted therapy and prognosis in asthma patients. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ХОББ и COVID-19(Македонско лекарско друштво. Македонското здружение за алергологија и клиничка имунологија, 2020-10); ; ; ; Златица Гошева - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Evaluation of IL-17 and FEF25-75 in patiants with uncontrolled moderate asthma(ERS, 2020); ; ; ; Zlatica Goseva